ArticleCancer immunology, immunotherapy : CII2024

COVID-19-sensitive tumour response: 2-year assessment of the SARS-CoV-2 humoral response in cancer patients in oncology hospital in Poland.

Piotr Kosiorek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.